IL-5 and IP-10 Detected in Quantiferon Supernatants Distinguish Latent Tuberculosis from Healthy Individuals in Areas with High Burden in Lima, Peru
Pathogens · 2025
DOI: 10.3390/pathogens14121225 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Nawal De la Peña Galindo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Innovation and Development Area, Instituto Nacional de Salud, Lima 15046, Peru. Hauptthemen laut MEDLINE: Chemokine CXCL10, Latent Tuberculosis, Interleukin-5. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica, PROCIENCIA-CONCYTEC-Peru, Instituto Nacional de Salud.
Abstract (Originalsprache)
Background
Peru ranks among the countries with the highest burden of tuberculosis in Latin America. Interferon Gamma Release Assays (IGRAs), such as QuantiFERON-TB (QFT), cannot distinguish latent tuberculosis infection (LTBI) from active tuberculosis (ATB), but they provide a more specific and quantitative assessment of prior exposure to Mycobacterium tuberculosis.
Methods
We enrolled 56 participants and measured 38 cytokines/chemokines from plasma obtained through QFT in patients with active TB (n = 11), LTBI (n = 17), and QFT-negative healthy controls (n = 28) using a Multiplex Bead Assay.
Results
Levels of IL-1RA, IL-2, IL-5, IFN-γ, and IP-10 significantly differentiated both ATB and LTBI groups from healthy controls (p < 0.035). Furthermore, IL-5 and IP-10 specifically distinguished LTBI from healthy controls (p < 0.015), while GM-CSF differentiated ATB from controls (p < 0.05).
Conclusions
Beyond IFN-γ as a differential proinflammatory cytokine in TB, cytokines such as IL-5, and IP-10 show potential as biomarkers to discriminate infection status in high-burden TB settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Innovation and Development Area, Instituto Nacional de Salud, Lima 15046, Peru.
- Health Technology Assessment Center, Instituto Nacional de Salud, Lima 15046, Peru.
- Virology Unit, Instituto Nacional de Salud, Lima 15046, Peru.
ORCID-Profile: Marco Galarza Perez
Förderung
- Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica
- PROCIENCIA-CONCYTEC-Peru
- Instituto Nacional de Salud
Zitieren
APA
De la Peña Galindo, N., Valdez, S. C., Neira, C. S., Calderon, H. B., Sanchez, G. S., Pelaez, F. P., & Galarza Perez, M. (2025). IL-5 and IP-10 Detected in Quantiferon Supernatants Distinguish Latent Tuberculosis from Healthy Individuals in Areas with High Burden in Lima, Peru. Pathogens. https://doi.org/10.3390/pathogens14121225
Vancouver
De la Peña Galindo N, Valdez SC, Neira CS, Calderon HB, Sanchez GS, Pelaez FP, et al. IL-5 and IP-10 Detected in Quantiferon Supernatants Distinguish Latent Tuberculosis from Healthy Individuals in Areas with High Burden in Lima, Peru. Pathogens. 2025. doi:10.3390/pathogens14121225
BibTeX
@article{DelaPeaGalindo2025,
author = {De la Peña Galindo, Nawal and Valdez, Silvia Capristano and Neira, Cesar Sanchez and Calderon, Henri Bailon and Sanchez, Gilmer Solis and Pelaez, Flor Peceros and Galarza Perez, Marco},
title = {IL-5 and IP-10 Detected in Quantiferon Supernatants Distinguish Latent Tuberculosis from Healthy Individuals in Areas with High Burden in Lima, Peru},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14121225}
}
EUVIMED